Daily Note 21/03/2023 – Market View: Day Ahead, Macro, Stocks, Debt Markets


  • Risk assets closed higher yesterday after a weak opening
  • Sanofi has announced yet another approval for blockbuster drug Dupixent, this time in Europe for the treatment of atopic dermatitis in children between the ages of six months and five years
  • A volatile session for core bonds yesterday with yields moving higher on the day